首页> Clinical pharmacology in drug development> A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

导出原文传递

翻译打印收藏纠错

第一作者： Adams,L.M.

作者： Adams,L.M. ^[1] ; Johnson,B. ; Murray,S.

作者单位： GlaxoSmithKline, Research Triangle Park, NC, United States ^[1]

关键词 Casopitant Cyclophosphamide Drug-drug interaction Pharmacokinetics

发布时间 2015-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacology in drug development

2014年3卷2期

93-100页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical pharmacology in drug development

2014年3卷2期

93-100页

检索历史清除

A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

Clinical pharmacology in drug development

相似文献

同项目论文

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

Clinical pharmacology in drug development

相似文献

同项目论文

Clinical pharmacology in drug development

相关期刊

检索历史清除